Péter Reményi

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Hajnalka Andrikovics, Tünde Krähling, Katalin Balassa et al. · Haematologica · 2014 · 98 citations · Full text

Somatic Insertions/deletions, Hematological Malignancy, Calreticulin Mutations +15

Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Nico Gagelmann, Diderik-Jan Eikema, Linda Köster et al. · Biology of Blood and Marrow Transplantation · 2019 · 85 citations · Full text

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

Nicola Polverelli, Katya Mauff, Nicolaus Kröger et al. · American Journal of Hematology · 2020 · 70 citations · Full text

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy‐driven survey

János Sinkó, Judit Csomor, Radka Nikolova et al. · Transplant Infectious Disease · 2007 · 57 citations

Invasive Fungal Disease, Diagnostic Mycology, Antifungal Agent +13